# S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer

> **NCT00043082** · PHASE3 · COMPLETED · sponsor: **SWOG Cancer Research Network** · enrollment: 61 (actual)

## Conditions studied

- Ovarian Cancer
- Peritoneal Cavity Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** pegylated liposomal doxorubicin hydrochloride

## Key facts

- **NCT ID:** NCT00043082
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08
- **Primary completion:** 2007-06
- **Final completion:** 2011-07
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2015-10-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00043082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00043082, "S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00043082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*